ZENBEKEBI Trademark

Trademark Overview

On Tuesday, July 23, 2024, a trademark application was filed for ZENBEKEBI with the United States Patent and Trademark Office. The USPTO has given the ZENBEKEBI trademark a serial number of 98662461. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, May 22, 2025. This trademark is owned by Celgene Corporation. The ZENBEKEBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
zenbekebi

General Information

Serial Number98662461
Word MarkZENBEKEBI
Filing DateTuesday, July 23, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, May 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Trademark Events

Event DateEvent Description
Tuesday, July 23, 2024NEW APPLICATION ENTERED
Monday, February 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 11, 2025ASSIGNED TO EXAMINER
Wednesday, February 12, 2025NON-FINAL ACTION E-MAILED
Friday, May 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 12, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2025NON-FINAL ACTION WRITTEN
Saturday, May 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

zenbekebi diseases preparations purposes disease cancer medical treatment diagnostic solid radiopharmaceutical